Financials DocGo Inc.

Equities

DCGO

US2560861096

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
3.62 USD +0.28% Intraday chart for DocGo Inc. +3.13% -35.24%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 146 935.6 724 580.8 369.3 - -
Enterprise Value (EV) 2 146 935.6 724 554.5 256.6 199.5 140.4
P/E ratio -0.06 x 37.4 x 20.8 x 93.2 x 11.4 x 9.16 x 6.11 x
Yield - - - - - - -
Capitalization / Revenue - 2.94 x 1.64 x 0.93 x 0.52 x 0.55 x 0.59 x
EV / Revenue - 2.94 x 1.64 x 0.89 x 0.36 x 0.3 x 0.22 x
EV / EBITDA - 37.3 x 17.5 x 10.3 x 3.18 x 2.14 x 1.45 x
EV / FCF - -88,799,836 x - - - - -
FCF Yield - -0% - - - - -
Price to Book - - - 1.93 x 1.06 x 0.91 x 0.78 x
Nbr of stocks (in thousands) 14,375 100,069 102,411 103,896 102,030 - -
Reference price 3 37.30 34.34 25.96 20.53 13.30 13.30 13.30
Announcement Date 7/2/21 3/14/22 3/13/23 2/28/24 - - -
1AED in Million2USD in Million3AED
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 318.7 440.5 624.3 714.3 674.7 626.2
EBITDA 1 - 25.1 41.3 54 80.74 93.08 96.63
EBIT 1 - 15.36 21.83 15.05 41.82 54.88 -
Operating Margin - 4.82% 4.96% 2.41% 5.86% 8.13% -
Earnings before Tax (EBT) 1 - 19.8 22.78 16.29 42.83 56.89 -
Net income 1 -14.36 23.74 34.58 6.858 37.44 48.98 65.99
Net margin - 7.45% 7.85% 1.1% 5.24% 7.26% 10.54%
EPS 2 -584.0 0.9182 1.249 0.2204 1.170 1.452 2.177
Free Cash Flow - -10.54 - - - - -
FCF margin - -3.31% - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 7/2/21 3/14/22 3/13/23 2/28/24 - - -
1USD in Million2AED
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 85.84 121.3 117.9 109.5 104.3 108.8 113 125.5 186.6 199.2 187.9 180.9 172.2 173.3 185.3
EBITDA 1 3.539 17.3 13.6 12.3 8.4 6.8 5.6 9.1 16.7 22.6 19.96 19.95 20.31 20.58 21.95
EBIT 1 1.519 15.45 10.09 7.458 4.199 0.0801 -6.903 1.576 8.708 11.67 10.36 10.14 10.71 10.62 15.56
Operating Margin 1.77% 12.74% 8.56% 6.81% 4.03% 0.07% -6.11% 1.26% 4.67% 5.86% 5.51% 5.6% 6.22% 6.13% 8.4%
Earnings before Tax (EBT) 1 - 20.28 9.813 12.08 2.868 -1.977 -6.049 0.9886 9.157 12.2 10.57 10.38 10.97 10.9 16.07
Net income 1 - 23.56 10.63 12.74 3.154 8.065 -3.466 -2.011 4.765 7.57 8.885 8.903 9.315 9.439 12.41
Net margin - 19.42% 9.02% 11.63% 3.02% 7.41% -3.07% -1.6% 2.55% 3.8% 4.73% 4.92% 5.41% 5.45% 6.69%
EPS 2 - 0.2204 0.3306 0.4041 0.1102 0.3673 -0.1102 -0.0735 0.1837 0.2571 0.3016 0.2796 0.2826 0.2851 0.4265
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/15/21 3/14/22 5/9/22 8/8/22 11/7/22 3/13/23 5/8/23 8/7/23 11/6/23 2/28/24 - - - - -
1USD in Million2AED
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - - 26.3 113 170 229
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - -10.5 - - - - -
ROE (net income / shareholders' equity) - - - 2.39% 15.5% 14.9% 14.8%
ROA (Net income/ Total Assets) - - - 1.55% 9.99% 10.2% 10.4%
Assets 1 - - - 442.5 374.9 480.8 634.1
Book Value Per Share 2 - - - 10.60 12.60 14.60 16.90
Cash Flow per Share 2 - - - - 2.460 2.160 2.230
Capex 1 - 4.81 - 7.58 4 4 4
Capex / Sales - 1.51% - 1.21% 0.56% 0.59% 0.64%
Announcement Date 7/2/21 3/14/22 3/13/23 2/28/24 - - -
1USD in Million2AED
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.3 AED
Average target price
35.52 AED
Spread / Average Target
+167.17%
Consensus